This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Takatoshi Tamura: Innovator in Feline Health
Introduction
Takatoshi Tamura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the treatment of respiratory diseases in cats. His innovative approach has the potential to improve the quality of life for both pets and their owners.
Latest Patents
Tamura holds a patent for a therapeutic agent designed for cat respiratory diseases. This patent, titled "Therapeutic agent for cat respiratory diseases and method of treatment," describes a method that utilizes a human interferon as an effective ingredient. The therapeutic agent demonstrates strong efficacy in treating cats, requiring only a small dose for administration, whether orally or parenterally. This innovation significantly reduces the labor and burden faced by veterinarians and cat owners alike.
Career Highlights
Throughout his career, Takatoshi Tamura has worked with several prominent companies in the veterinary field. Notable among these are Hayashibara Biochemical Laboratories, Inc. and Biovet, Inc. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in animal health.
Collaborations
Tamura has collaborated with esteemed colleagues, including Yoshikatsu Miwa and Hitoshi Murasaki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in veterinary medicine.
Conclusion
Takatoshi Tamura's contributions to feline health through his innovative patent highlight the importance of research and development in veterinary medicine. His work not only benefits cats but also alleviates the challenges faced by their caregivers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
